CVE-2023-6260

Brivo Acs100 Firmware command injection

9.0 CRITICALEPSS 0.90%

Published19 Feb 2024

Description

Improper Neutralization of Special Elements used in an OS Command ('OS Command Injection') vulnerability in Brivo ACS100, ACS300 allows OS Command Injection, Bypassing Physical Security.This issue affects ACS100 (Network Adjacent Access), ACS300 (Physical Access): from 5.2.4 before 6.2.4.3.

CVSS 3.1 breakdown

Attack vectorAdjacent

Attack complexityLow

Privileges requiredLow

User interactionNone

ScopeChanged

ConfidentialityHigh

IntegrityHigh

AvailabilityHigh

CVSS:3.1/AV:A/AC:L/PR:L/UI:N/S:C/C:H/I:H/A:H

Affected products

Brivo Acs100 Firmware≥ 5.2.4 ≤ 6.2.4.3

Brivo Acs300 Firmware≥ 5.2.4 < 6.2.4.3

Remediation

Fixed in

Brivo Acs300 Firmware≥ 6.2.4.3

Frequently asked

Is CVE-2023-6260 being actively exploited?

CVE-2023-6260 is not in the CISA KEV catalog. Its EPSS exploit probability is 0.90%.

How severe is CVE-2023-6260?

CVE-2023-6260 has a CVSS 3.1 base score of 9.0, rated critical. EPSS estimates a 0.90% probability of exploitation.

Which products are affected by CVE-2023-6260?

Affected products include Brivo Acs100 Firmware, Brivo Acs300 Firmware.

How do I fix CVE-2023-6260?

Upgrade affected software to a fixed version, for example Brivo Acs300 Firmware 6.2.4.3 or later, then confirm no affected versions remain in your inventory.

How Secuno handles this

Secuno correlates vulnerabilities like CVE-2023-6260 against the real software inventory on every managed device, every day. Rather than a static severity, each match is scored in context: exploit availability, EPSS, the asset's exposure, and business criticality decide where it lands in the queue. If an affected version is present anywhere across your portfolio, it surfaces automatically with a prioritised remediation path.

See how prioritisation works Book a demo

Data from the NVD, CISA KEV catalog and FIRST EPSS. CVSS 3.1 base score shown where available.